Study Of Yttrium-ibritumomab (Zevalin) For the Treatment Of Patients With Relapsed And Refractory Mantle Cell Lymphoma

This study has been completed.

Study NCT00038623 Information provided by M.D. Anderson Cancer Center

First Received: June 3, 2002 Last Updated: October 31, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	February 2010
Primary Completion Date:	December 2007 (Final data collection date for primary outcome measure)